Intellectual Property special counsel Christine Willgoos and associate Shannon H. Hedvat wrote an article titled "Personal Jurisdiction in Hatch-Waxman Cases Uncertain After Daimler", that appeared in Bloomberg BNA's Pharmaceutical Law and Industry Report on May 1, 2015. The article discusses how the Supreme Court's decision in Daimler AG v. Bauman could impact personal jurisdiction in Hatch-Waxman cases.